Quarterly Result11 Aug 2026, 06:10 pm
Bafna Pharma Declares Unaudited Q1 FY27 Results; AGM on Sep 11
AI Summary
Bafna Pharmaceuticals Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors approved these results on August 11, 2026. The company also announced its 31st Annual General Meeting (AGM) will be held on September 11, 2026, through Video Conferencing. The book closure for the AGM will be from September 5 to September 11, 2026, with a cut-off date of September 4, 2026, for determining voting eligibility. The Board meeting to approve these results commenced at 2:30 PM and concluded at 4:00 PM IST.
Key Highlights
- Bafna Pharma declared unaudited financial results for Q1 FY27.
- The Board of Directors approved the results on August 11, 2026.
- The 31st AGM is scheduled for September 11, 2026.
- Book closure is from September 5 to September 11, 2026.
- Cut-off date for AGM voting eligibility is September 4, 2026.
Price Impact
More from BAFNAPH